Home News

Boehringer Ingelheim launches ‘LastMile’ initiative to address major barriers in animal healthcare sector in Sub-Saharan Africa

The initiative is established by Boehringer Ingelheim and supported by GALVmed Nairobi, Kenya – 4 July 2018– Boehringer Ingelheim, one of the world’s leading pharmaceutical companies, announced today the launch of the ‘LastMile Initiative’, an integrated, solutions-driven program that seeks to address crucial animal health challenges by creating consistent availability of animal medical resources in […]

A message from our new Chief Executive, Carolin Schumacher

It is a great honour and pleasure for me to have been appointed as the new CEO of GALVmed. I join the organisation at a moment where GALVmed can look back proudly onto 10 years of successful operations and has established a solid foundation of experienced staff, strong partners and good funding. Let us stop […]

Funding for Tryps Phase 3 approved

GALVmed has received funding approval totalling to US$ 19 million for the Phase 3 programme on Improved Tools for the Control of Animal African Trypanosomosis (Tryps 3). The main objective of the programme, which is co-funded by the UK Government and Bill & Melinda Gates Foundation, is to commercially develop a registered therapeutic trypanocidal product […]

Peter Wells retires from GALVmed Board

In September 2018 Dr Peter Wells retired from GALVmed’s Board of Trustees. Peter became involved with GALVmed initially through the Expert Scientific Advisory Committee before involvement in the governance of GALVmed early 2011. After a brief period as interim CEO Peter was formally appointed as a trustee in April 2012. During his time as trustee […]

East African countries register first veterinary product under new Mutual Recognition Procedures

Arusha, 1st October 2018 – The first licences for a veterinary vaccine submitted for registration under the East African Community’s Mutual Recognition Procedure (MRP) have been issued. Obtaining approval to place veterinary medicines on the market requires a marketing authorisation (licence) from the National Regulatory Authority in each country where the product is to be […]

GALVmed gets a new Chief Executive

(10 August 2018, Edinburgh, UK)-The Board of GALVmed is pleased to announce the appointment of Dr. Carolin Schumacher as the new Chief Executive Officer of GALVmed. Carolin was appointed following a rigorous and open recruitment process from a pool of promising candidates. Dr. Peter Jeffries, current Chief Executive of GALVmed since 2013, announced in April […]

GALVmed gets a new Chief Executive

The Board of GALVmed is pleased to announce the appointment of Dr. Carolin Schumacher as the new Chief Executive Officer of GALVmed. Carolin was appointed following a rigorous and open recruitment process from a pool of promising candidates. Dr. Peter Jeffries, current Chief Executive of GALVmed since 2013, announced in April 2018 his intention to […]

Global network to eradicate PPR is launched

GALVmed representatives Jeremy Salt and Mark Rweyemamu are this week attending a meeting in Vienna, Austria, to launch the Peste des petits ruminants Global Research and Expertise Network (PPR-GREN). The PPR-GREN network was established and endorsed in 2015 to support a global strategy to eradicate PPR. Peste des petits ruminants,or simply known as PPR, was […]

Letter from our CEO: Changes at the top

After more than 5 years leading GALVmed, and having recently received our latest round of funding, the time has come to consider my retirement. At our recent Board meeting in Casablanca, I indicated to the Board my intention to step down as Chief Executive. The process of selecting my successor will start shortly and I […]

International Research Consortium on Animal Health: March 2018 Newsletter

Jeremy Salt, our Chief Scientific Officer attended two meetings highlighted in this March edition of  STAR-IDAZ. Jeremy is a member of the scientific committee of International Research Consortium on Animal Health. Read more.

1 2 3 20